Felipe Lopez-Ramirez, Mohammad Yasrab, Florent Tixier, Satomi Kawamoto, Elliot K Fishman, Linda C Chu
Semin Nucl Med . 2025 Feb 28:S0001-2998(25)00012-1. doi: 10.1053/j.semnuclmed.2025.02.003. Online ahead of print.
Advancements in Artificial Intelligence (AI) are driving a paradigm shift in the field of medical diagnostics, integrating new developments into various aspects of the clinical workflow. Neuroendocrine neoplasms are a diverse and heterogeneous group of tumors that pose significant diagnostic and management challenges due to their variable clinical presentations and biological behavior. Innovative approaches are essential to overcome these challenges and improve the current standard of care. AI-driven applications, particularly in imaging workflows, hold promise for enhancing tumor detection, classification, and grading by leveraging advanced radiomics and deep learning techniques. This article reviews the current and emerging applications of AI computer vision in the care of neuroendocrine neoplasms, focusing on its integration into imaging workflows, diagnostics, prognostic modeling, and therapeutic planning.